Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
J Rheum Dis. 2016 Jun;23(3):141-147. English. Review. https://doi.org/10.4078/jrd.2016.23.3.141
Jeong WJ , Kim HJ .
Department of Orthopedic Surgery, Kyungpook National University School of Medicine, Daegu, Korea.
Department of Physiology, Kyungpook National University School of Medicine, Daegu, Korea. kimhajeong@knu.ac.kr
Abstract

Osteoclasts are a major component of bone metabolism in physiologic condition and in rheumatoid arthritis (RA). RA is a chronic, autoimmune, inflammatory disease primarily affecting the joints. Joint inflammation leads to cartilage and bone destruction by osteoclast activation. This osteoclast activation leads to typical RA symptoms and is the therapeutic target. Several kinds of drugs are used for preventing bone loss by osteoclasts in RA patients. However, the bone destructive action of osteoclasts is not the only mechanism in RA pathogenesis. Recent research suggests that the osteoclasts regulate hematopoietic stem cell niches and invoke immune responses in bone. Osteoclasts are derived from bone marrow hematopoietic stem cells, and maintain the hematopoietic stem cell niches contract with osteoblasts. Osteoclasts secret several cytokines to regulate inflammation and T cell differentiation, and present antigen to T cells via major histocompatibility complex class I and class II molecules. Osteoclast concepts in both origins and functions are under major reconsideration and research. In this review, we will discuss these new insights.

Copyright © 2019. Korean Association of Medical Journal Editors.